Sean Aronow
14Patents
4h-index
43Co-inventors
52Inventor score
Filing activity: Dec 29, 2017 → Jun 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10112942B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 14 | Active |
| US10172851B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US10137124B2 | Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US10144734B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US10555944B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US10172845B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10881652B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10953005B1 | Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11873295B2 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | Chemistry; Metallurgy | 1 | Active |
| US11878970B2 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | Chemistry; Metallurgy | 0 | Active |
| US10441581B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11648243B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11649227B2 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | Chemistry; Metallurgy | 0 | Active |
| US11998545B2 | Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.